AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Guggenheim Analyst Says
AbbVie (NYSE:ABBV – Get Free Report) had its price target hoisted by equities researchers at Guggenheim from $214.00 to $216.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Guggenheim’s price objective would indicate a potential upside of 10.68% from the company’s previous close. Several other […]
AbbVie (NYSE:ABBV – Get Free Report) had its price target hoisted by equities researchers at Guggenheim from $214.00 to $216.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Guggenheim’s price objective would indicate a potential upside of 10.68% from the company’s previous close. Several other […]
